Reumatolog Ali Theibich ApS: Financial statements 2018
CVR: 39336022
Source: annual report 2018, Danish Business Authority
01/02/2018 – 31/12/2018
Reumatolog Ali Theibich ApS (CVR 39336022) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 187,824 and a net result of DKK 9,820. Equity in the 2018 report amounted to DKK 9,821. The solvency ratio was 30.1%.
- Gross Profit
- DKK 187,824
- Profit/Loss
- DKK 9,820
- Equity
- DKK 9,821
- Total Assets
- DKK 32,575
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of February 1, 2018, Ali Ahmed Theibich is registered as adm. dir. of Reumatolog Ali Theibich ApS.
As of February 1, 2018, Speciallægen Wedian Holding ApS is registered as an owner of Reumatolog Ali Theibich ApS with an ownership share of 100%.
Reumatolog Ali Theibich ApS was founded on February 1, 2018.
About Reumatolog Ali Theibich ApS
Reumatolog Ali Theibich ApS is a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Ali Theibich IVS. The management consists of Ali Ahmed Theibich. The company is owned by Speciallægen Wedian Holding ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,497,333 and a net result of DKK -92,479 compared with DKK 216,289 the year before. Equity in the 2025 report amounted to DKK 1,265,681.
